rs142926942
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_002087.4(GRN):c.1540G>A(p.Val514Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000165 in 1,613,926 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002087.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRN | ENST00000053867.8 | c.1540G>A | p.Val514Met | missense_variant | Exon 12 of 13 | 1 | NM_002087.4 | ENSP00000053867.2 | ||
GRN | ENST00000589265.5 | c.1069G>A | p.Val357Met | missense_variant | Exon 8 of 9 | 5 | ENSP00000467616.1 | |||
GRN | ENST00000586443.1 | c.979G>A | p.Val327Met | missense_variant | Exon 7 of 7 | 3 | ENSP00000465673.1 | |||
GRN | ENST00000586242.1 | c.172G>A | p.Val58Met | missense_variant | Exon 2 of 3 | 3 | ENSP00000467837.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251362Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135894
GnomAD4 exome AF: 0.000177 AC: 259AN: 1461752Hom.: 1 Cov.: 34 AF XY: 0.000172 AC XY: 125AN XY: 727190
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74358
ClinVar
Submissions by phenotype
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;C3539123:Neuronal ceroid lipofuscinosis 11 Uncertain:2
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 514 of the GRN protein (p.Val514Met). This variant is present in population databases (rs142926942, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of GRN-related conditions (PMID: 18565828, 18838661, 22312439, 30279455). ClinVar contains an entry for this variant (Variation ID: 587957). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GRN protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on GRN function (PMID: 30279455). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:2
GRN: PM2, BP4 -
Functional studies demonstrate that the V514M variant has no effect on the expression or secretion of progranulin or its ability to be processed by proteases (PMID: 26811050); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22312439, 18565828, 26811050, 18838661, 31617930, 24252647, 30279455) -
Inborn genetic diseases Uncertain:1
The p.V514M variant (also known as c.1540G>A), located in coding exon 11 of the GRN gene, results from a G to A substitution at nucleotide position 1540. The valine at codon 514 is replaced by methionine, an amino acid with highly similar properties. This variant has been reported in individuals with Alzheimer and Parkinson disease but without a confirmed diagnosis of frontotemporal lobar degeneration (FTLD) (Brouwers N et al. Neurology. 2008;71:656-64; Nuytemans K et al. Neurology. 2008;71:1147-51). This alteration was also reported in one individual with early onset Alzheimer disease in a cohort of 3241 patients with dementia as compared to 13/141352 individuals in the gnomAD database (Koriath C et al. Mol. Psychiatry, 2018; [Epub ahead of print]). A functional study found this variant did not have a significant effect on GRN secretion (Kleinberger G et al. Neurobiol Aging. 2016;39:220.e17-26). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at